Henry Ford Health

Henry Ford Health Scholarly Commons
Dermatology Articles

Dermatology

8-1-2021

International Classification of Diseases-based analysis is
inaccurate in assessing the prevalence of inflammatory bowel
disease in patients with hidradenitis suppurativa
Daniel A. Gold
Henry Ford Health, dgold1@hfhs.org

Cynthia Nicholson
Henry Ford Health

Gordon Jacobsen
Henry Ford Health, gjacobs2@hfhs.org

Iltefat H. Hamzavi
Henry Ford Health, ihamzav1@hfhs.org

Follow this and additional works at: https://scholarlycommons.henryford.com/dermatology_articles

Recommended Citation
Gold DA, Nicholson C, Jacobsen G, and Hamzavi IH. International Classification of Diseases-based
analysis is inaccurate in assessing the prevalence of inflammatory bowel disease in patients with
hidradenitis suppurativa. J Am Acad Dermatol 2021.

This Article is brought to you for free and open access by the Dermatology at Henry Ford Health Scholarly
Commons. It has been accepted for inclusion in Dermatology Articles by an authorized administrator of Henry Ford
Health Scholarly Commons.

J AM ACAD DERMATOL
VOLUME 85, NUMBER 2

Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island,
South Carolina, Tennessee, Texas, Virginia, Washington,
and Wyoming. We would also like to thank Ernesto
Llamado and Jeanette Torres for their help with submission of this manuscript. The authors assume full responsibility for analyses and interpretation of these data.

Aaron M. Drucker, MD, ScM,a,b,c Wen-Qing Li,
PhD,a,d Eunyoung Cho, ScD,a,d,e Tricia Li, MSc,e
Richard Besdine, MD,f Abrar A. Qureshi, MD,
MPH,a,b,d,e and Eleni Linos, MD, MPH, DrPHg
From the Department of Dermatology, Warren
Alpert Medical School of Brown University, Providence, Rhode Islanda; Department of Dermatology, Rhode Island Hospital, Providence, Rhode
Islandb; Division of Dermatology, Department of
Medicine, Women’s College Hospital and University of Toronto and Women’s College Research
Institute, Toronto, Ontario, Canadac; Department of Epidemiologyd and Center for Gerontology and Health Care Research, School of
Public Health, Brown University, Providence,
Rhode Islandf; Channing Division of Network
Medicine, Department of Medicine, Brigham
and Women’s Hospital and Harvard Medical
School, Boston, Massachusettse; and Program in
Clinical Research, Department of Dermatology,
University of California San Francisco, San
Francisco, California.g
Funding sources: Supported in part by the Department of Dermatology of Brown University. Dr
Drucker received SURDNA fellowship funding for
this project from the Center for Gerontology and
Health Care Research, School of Public Health,
Brown University. Dr Li is supported by the
Richard B. Salomon Faculty Research Award
from Brown University and a Research Career
Development Award from the Dermatology
Foundation. Dr Linos is supported by a National
Institute on Aging Beeson grant (K76AG054631)
and a University of California San Francisco
Pepper Center grant (NIH P30AG044281). The
work was supported by a National Institutes of
Health grant for the Nurses’ Health Study (UM1
CA186107 and P01 CA87969), and the Health
Professionals Follow-up Study (UM1 CA167552).
Disclosure: Dr Drucker served as an investigator
for and has received research funding from
Sanofi and Regeneron and has been a consultant for Sanofi and RTI Health Solutions; he has
received honoraria from Astellas Canada, Prime
Inc, Spire Learning, and the Eczema Society of
Canada. Dr Qureshi has received honoraria

Research Letters 495

(that have been donated to charity) from Abbvie,
Amgen, Centers for Disease Control, Janssen,
Merck, Novartis, Pfizer (as a consultant), and
Amgen (as an investigator), and he is an
investigator for Sanofi and Regeneron. Dr Li,
Dr Cho, Ms Li, Dr Besdine, MD, and Dr Linos
have no conflicts of interest to disclose.
The funding sources had no role in study design; in
the collection, analysis, and interpretation of
data; in the writing of the report; or in the
decision to submit the article for publication.
Reprints not available from the authors.
Correspondence to: Abrar A. Qureshi, MD, MPH,
Rhode Island Hospital, 593 Eddy St, APC-10,
Providence, RI 02903
E-mail: abrar_qureshi@brown.edu
REFERENCES
1. McElhaney JE, Effros RB. Immunosenescence: what does it
mean to health outcomes in older adults? Curr Opin Immunol.
2009;21:418-424.
2. van Dam RM, Huang Z, Giovannucci E, et al. Diet and basal cell
carcinoma of the skin in a prospective cohort of men. Am J Clin
Nutr. 2000;71:135-141.
3. Colditz GA, Martin P, Stampfer MJ, et al. Validation of
questionnaire information on risk factors and disease outcomes
in a prospective cohort study of women. Am J Epidemiol. 1986;
123:894-900.
4. Hartevelt MM, Bavinck JN, Kootte AM, Vermeer BJ,
Vandenbroucke JP. Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation. 1990;49:506-509.
https://doi.org/10.1016/j.jaad.2018.07.049

International Classification of
Diseasesebased analysis is
inaccurate in assessing the
prevalence of inflammatory bowel
disease in patients with hidradenitis
suppurativa
To the Editor: Chronic inflammatory skin diseases,
including psoriasis and rosacea, have been associated
with inflammatory bowel disease (IBD). Recent
population-based studies have found a similar
association with hidradenitis suppurativa (HS) and
IBD. Population-based studies potentially misrepresent the true prevalence of a disease.1 The aim of our
study was to investigate a possible association
between HS and IBD by using data pull analysis
from the International Classification of Diseases,
Ninth Revision (ICD-9), and International
Classification of Diseases, 10th Revision (ICD-10),
codes and data verification by complete chart review.
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Table I. Documentation of IBD in patients with HS and controls
Result

HS group
(n = 983)

Control group
(n = 983)

Chi-square comparison
P value

Positive according to ICD
Positive according to chart review ( prevalence)
False-positive result, n (%)

56 (5.7%)
20 (2.0%)
36 (3.7%)

15 (1.5%)
0 (0.0%)
15 (1.5%)

\.001
\.001
.003

Boldface indicates statistical significance (P \ .05).
HS, Hidradenitis suppurativa; ICD, International Classification of Diseases.

We performed a retrospective chart review of
dermatology visits from January 1, 2005, to May 31,
2016. Charts of patients with the ICD-10 diagnostic
code L73.2 and ICD-9 diagnostic code 705.83 for HS
were pulled. A total of 4576 subjects with HS were
identified as having 2 or more visits to dermatology
with a diagnosis of HS. The HS population was
cross-referenced with the diagnosis of IBD by using
the ICD-10 codes K51, K50, and K52.9 and the ICD-9
codes 555 and 556. An age-, race-, and sex-matched
control population was created from subjects with
diagnoses of either keloids or verruca vulgaris.
Patients were cross-matched with the diagnosis of
IBD. A diagnosis of IBD required confirmation by a
gastroenterologist and utilization of a previously
reported protocol.2
The IBD prevalence rates were compared
between the HS and control groups by using the
chi-square test.
There were 986 cases of HS identified. ICD
coding identified 56 patients as also having IBD.
After a chart review, 20 cases were verified.
Crohn’s disease was diagnosed in 12 cases and
ulcerative colitis in 7 cases. One patient had both
Crohn’s disease and ulcerative colitis. The
false-positive rate was 3.7%. The prevalence of
IBD in patients with HS was 2.0%. In the control
group, 15 of the 983 patients were identified as
having IBD, yet none had IBD after chart
verification, resulting in a false-positive rate of
1.5% and a prevalence of IBD in the controls of 0.
There was a significantly increased risk of IBD in
the patients with HS compared with that in the
controls (P ¼ .001) (Table I).
We found that our population of patients with
HS had a higher rate of IBD when compared with
the controls. Specifically, subjects with HS were
significantly more likely to have both Crohn’s
disease and ulcerative colitis. As in prior reports,
our data support the predominance of Crohn’s
disease over ulcerative colitis.3 Our prevalence of
IBD in patients with HS of 2% is more than 6 times
higher than that reported for the general
population.4 We found that relying on ICD
diagnostic codes resulted in a significant number

of false-positive cases (3.7% in our HS population
and 1.5% in our controls). The ICD diagnosis
overstated the association of HS and IBD by a
factor of 2.8 (5.7% of cases were initially identified
as IBD, whereas only 2.0% were actual cases). A
careful chart review was necessary to make an
accurate diagnosis.
Our results indicate that the risk of IBD in patients
with HS is 6 times higher than risk of IBD in the
general population. We found that the utilization of
ICD coding alone could overestimate disease
prevalence by a factor of 2.8.
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Rouleaux: A microscopic clue that
helps distinguish psoriasis from
dermatitis
To the Editor: Psoriasis is a common, chronic
inflammatory skin disease affecting 2%-3% of the
US population.1 The histologic appearance of
psoriasis is variable and depends on the stage and
type of lesion biopsied.2 In addition, other
spongiotic dermatitides are often included in both
the clinical and pathologic differential diagnosis,
which can make definitive diagnosis difficult.3,4
Rouleaux formation, or aggregates of red blood
cells resembling a stack of coins (Fig 1), occurs
through interactions with increased plasma protein
or acute phase reactants, with binding mediated by
sialic acid. Although rouleaux formation has been
described as a finding characteristic of psoriasis, this
observation has not been validated; the phenomenon might also occur with other forms of

Table I. Rouleaux
Rouleaux present
Diagnosis

Observer
1, n (%)

Observer
2, n (%)

Observer
3, n (%)

Average,
%



68
25
72

0.81
0.55
0.77

Psoriasis 62/100 (62) 70/100 (70) 73/100 (73)
Dermatitis 17/100 (17) 30/100 (30) 27/100 (27)
Benign
37/50 (74) 36/50 (72) 35/50 (70)
keratoses

inflammation, infection, and monoclonal gammopathy.5 In this study, we sought to investigate the
presence of rouleaux in psoriasis; other dermatitides
(including spongiotic dermatitis, stasis dermatitis,
pityriasis rosea, seborrheic dermatitis, tinea); and
benign keratosis (seborrheic keratosis and verruca
vulgaris).
Slides from cases of psoriasis (n ¼ 100), dermatitis
(n ¼ 100), and benign keratosis (n ¼ 50) were
obtained from a deidentified slide library of 1 of the
authors (Dr Elston). Each slide was reviewed
independently by 3 separate observers for the
presence of rouleaux, which was defined as $3 red
blood cells stacked on each other within the
superficial papillary dermal vasculature.
Rouleaux formation was far more common
among cases of psoriasis than dermatitis, with a
sensitivity and specificity of 68% and 75%,
respectively, and a positive likelihood ratio of 2.72.
However, we found that rouleaux formation is not a
finding unique to inflammatory conditions, as it was
noted in the majority of benign keratoses
evaluated. With regards to interobserver variability,
the kappa statistics ranged from moderate to
strong and are summarized in Table I. Our results
confirm that rouleaux formation is a helpful
feature for distinguishing psoriasis from other
dermatitides. Because of the small number of cases
included in our study, we were not able to take into
account the subtype of psoriasis biopsied. Future
studies evaluating rouleaux might provide further
information regarding this phenomenon.
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Fig 1. Rouleaux formation in psoriasis. Aggregates of red
blood cells (arrows) resembling stacks of coins in dermal
papillae.
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